Croton on Hudson, NY, United States of America

Jan Szeliga


 

Average Co-Inventor Count = 13.0

ph-index = 5

Forward Citations = 59(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovations of Jan Szeliga: A Focus on Opioid Receptor Antagonists

Introduction

Jan Szeliga, an accomplished inventor based in Croton on Hudson, NY, has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Szeliga's work primarily revolves around the development of compounds that play a crucial role in pain management and opioid receptor interactions.

Latest Patents

Among his latest patents, Szeliga has introduced innovative formulations of peripheral opioid receptor antagonists. The notable invention, titled "Peripheral Opioid Receptor Antagonists and Uses Thereof," details a specific compound of formula I, which includes components defined as X, R, and R, along with various compositions. This research holds great potential in the medical field for improving pain relief strategies.

Career Highlights

Jan Szeliga serves as a key innovator at Wyeth, a prominent pharmaceutical company recognized for its commitment to advancing health science. His expertise in drug development and receptor antagonism has positioned him as a leader in his field, contributing to the design of therapies aimed at alleviating opioid-induced side effects.

Collaborations

Szeliga has had the privilege of working alongside talented colleagues, including Nataliya Bazhina and George Joseph Donato III. Together, they have fostered a collaborative environment that encourages innovative thinking and enhances the overall research output at Wyeth.

Conclusion

In summary, Jan Szeliga's innovative work in pharmacology and pain management signifies his impactful contributions to the healthcare industry. Through his patents and collaborations, he continues to advance the understanding and application of peripheral opioid receptor antagonists, paving the way for more effective therapeutic options in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…